INGN

5.3002.21%
GS

Glenn S. Boehnlein

Independent Director

Mr. Glenn S. Boehnlein, C.P.A. is Independent Director of DexCom, Inc. from September 10, 2026. Mr. Boehnlein is Independent Director of Agilent Technologies, Inc. from September 4, 2026. Mr. Boehnlein is Advisor of Stryker Corporation from April 1, 2025. Mr. Boehnlein was VP & CFO of Stryker Corporation from April 01, 2016 to March 31, 2025. Mr. Boehnlein joined the Stryker Corporation on April 01, 2016. He serves as Independent Director at Inogen, Inc. since March 22, 2022. Mr. Boehnlein has served on the Board of Directors of Sutter Healthcare System, a private company, since March 2024. He has been Chief Financial Officer and Vice President at Stryker Corporation since April 01, 2016. Mr. Boehnlein served as Group Vice President and Chief Financial Officer for Med Surg & Neurotechnology (MSNT) at Stryker Corporation since January 2011 until March 31, 2016. He joined Stryker in 2003 as the Vice President of Finance and IT for Stryker’s Endoscopy division and has taken on roles of increasing responsibility. He has a strong and established track record and continues to uphold the financial standards and practices that enable Stryker’s growth. Prior to joining Stryker, Mr. Boehnlein spent three years with MyPrimeTime as CFO. His career began with achieving a Certified Public Accountant degree and rising to Partner at Arthur Andersen, where he worked with large private and public companies, including private offerings and M&A transaction consulting. He then spent three years with Success TV as the company’s Chief Financial Officer prior to joining Stryker. Mr. Boehnlein received his Bachelor’s in Accountancy and Master’s in Professional Accountancy from Mississippi State University.

Positions